Back to Browse Journals » Drug, Healthcare and Patient Safety » Volume 1

Anti-metallothionein IgG and levels of metallothionein in autistic children with GI disease

Authors A J Russo

Published Date January 2009 Volume 2009:1 Pages 1—8

DOI http://dx.doi.org/10.2147/DHPS.S4342

Published 8 January 2009

A J Russo

Mount Saint Mary’s University, Emmitsburg, MD, USA

Aim: To assess both serum concentration of metallotionein (MT) and anti-metallothionein (anti-MT) immunoglobulin G (IgG) in autistic children with gastrointestinal (GI) symptoms and controls, and to test the hypothesis that there is an association between the presence of MT, anti-MT IgG, and inflammatory GI disease seen in many children with autistic spectrum disorder (ASD).

Subjects and methods: ELISAs were used to measure serum MT and anti-MT IgG in 41 autistic children with chronic digestive disease (many with ileo-colonic lymphoid nodular hyperplasia [LNH] and inflammation of the colorectum, small bowel, and/or stomach), and 33 controls (17 age-matched autistic children with no GI disease and 16 age-matched children without autism or GI disease).

Results: Ten of 41 autistic children with chronic digestive disease had high serum concentration of MT compared to only one of the 33 controls (p < 0.01). Thirteen of the 41 autistic children with chronic digestive disease had anti-MT IgG compared to only four of 33 controls (p < 0.01). Nine of 10 (90%) of autistic children with GI disease with high MT levels had a regressive onset (compared to the expected 25 of 41, or 61%, in this group) (p < 0.05), whereas only nine of 13 of the autistic children with GI disease and anti-MT IgG had a regressive onset (70%) which was not significantly higher than the expected. We didn’t find any correlation between severity of GI disease and MT concentration or anti-MT IgG.

Discussion: These results suggest a relationship between MT, anti-MT IgG and GI disease seen in many ASD individuals.

Keywords: autism, metallothionein, anti-metallothionein, GI disease

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Low serum myeloperoxidase in autistic children with gastrointestinal disease

Anthony J Russo, Arthur Krigsman, Bryan Jepson, et al

Clinical and Experimental Gastroenterology 2009, 2:85-94

Published Date: 11 August 2009

Readers of this article also read:

Aerosol delivery by an ultrasonic nebulizer during different mechanical ventilation settings in a lung model – a pilot study

Michael Winterhalter, Michael Bund, Nawid Khaladj, Christian Hagl, Andre Simon, et al

Drug Design, Development and Therapy 2008, 2:1-7

Published Date: 8 January 2008

Structure-based design of anticancer prodrug PABA/NO

Xinhua Ji, Ajai Pal, Ravi Kalathur, Xun Hu, Yijun Gu, et al

Drug Design, Development and Therapy 2008, 2:123-130

Published Date: 11 August 2008

Local anesthetic failure associated with inflammation: verification of the acidosis mechanism and the hypothetic participation of inflammatory peroxynitrite

Takahiro Ueno, Hironori Tsuchiya, Maki Mizogami, Ko Takakura

Journal of Inflammation Research 2008, 1:41-48

Published Date: 13 November 2008

Chryseomonas luteola: an unusual clinical infection mimicking a mediastinal malignant lymphoma

Gaia Goteri, Gerry M Dorrestein, Ester Manso, et al

Pathology and Laboratory Medicine International 2010, 2:137-139

Published Date: 1 December 2010

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer

Channing J Paller, Emmanuel S Antonarakis

Drug Design, Development and Therapy 2011, 5:117-124

Published Date: 10 March 2011

Filament formation associated with spirochetal infection: a comparative approach to Morgellons disease

Middelveen MJ, Stricker RB

Clinical, Cosmetic and Investigational Dermatology 2011, 4:167-177

Published Date: 14 November 2011